Feingold syndrome is a rare genetic condition defined by a distinctive cluster of physical features: unusually short fingers with specific bone abnormalities, a small head, short stature, characteristic facial features, and, in many cases, blockages in the esophagus or upper intestine that require surgery shortly after birth. Mild learning difficulties are also part of the picture. The syndrome comes in two types, each caused by a different gene, but both produce strikingly similar physical traits. Because it is rare and its features can overlap with other syndromes, Feingold syndrome is often missed or misdiagnosed, making genetic testing the linchpin of a reliable diagnosis.
The Core Features
The hallmark signs of Feingold syndrome type 1 are digital anomalies (finger and toe abnormalities), microcephaly (a head circumference smaller than expected), facial dysmorphism, short stature, atresia of the esophagus or duodenum, and mild learning disabilities.1PubMed. Rare features in Feingold syndrome type 1 Not every person with Feingold syndrome has all of these features, and severity varies widely even within the same family. Some children come to medical attention within hours of birth because of feeding difficulties caused by esophageal atresia, while others are identified later when clinicians notice the hand anomalies or head size during routine checkups.
The facial features tend to be subtle rather than dramatic. They can include a short nose with a broad tip, a thin upper lip, and mildly set-back ears, but these features are often described as “dysmorphic” only in the context of the other findings. Taken alone, they would rarely prompt a genetics referral. It is the combination of a small head, short fingers, and gastrointestinal problems in the same child that typically raises suspicion.
Hand and Foot Abnormalities
The finger and toe findings are the most consistent clue. The second and fifth fingers are characteristically affected, showing clinodactyly, which means they curve inward. This curvature happens because the middle bone of the finger (the middle phalanx) is either abnormally short or missing entirely.2PubMed. Feingold syndrome On X-ray, this shortened or absent middle phalanx is one of the most recognizable radiographic signs. In the feet, the corresponding finding is syndactyly, meaning webbing or fusion between toes, most commonly affecting the second and third toes. Shortened middle phalanges of the lateral toes are also described as a cardinal sign.2PubMed. Feingold syndrome
These digital anomalies can be easy to overlook in a newborn, especially when the medical team’s attention is focused on more urgent problems like esophageal atresia. A careful hand X-ray, however, can reveal the bony changes even when the external appearance of the fingers looks close to normal. Increased spacing between the first and second toes has also been reported and can be a helpful additional clue.3PubMed. Feingold syndome: a rare but important cause of syndromic tracheoesophageal fistula
Gastrointestinal Blockages
Esophageal atresia, often accompanied by a tracheoesophageal fistula (an abnormal connection between the esophagus and windpipe), is one of the most medically urgent features. In affected newborns, the esophagus ends in a blind pouch instead of connecting to the stomach, so the baby cannot swallow. This requires surgical repair within the first days of life. Duodenal atresia, a blockage in the first part of the small intestine, is another gastrointestinal finding that can appear in Feingold syndrome and also demands early surgical intervention.
Not every child with Feingold syndrome is born with atresia, and the gastrointestinal involvement varies. Some have no blockages at all, while others face complex surgical scenarios. What makes Feingold syndrome an important diagnosis to consider in any newborn presenting with esophageal atresia alongside microcephaly and digital anomalies is that recognizing the syndrome changes the family’s genetic counseling: since Feingold syndrome type 1 follows autosomal dominant inheritance, each child of an affected parent has a 50 percent chance of inheriting the condition.3PubMed. Feingold syndome: a rare but important cause of syndromic tracheoesophageal fistula
Two Genetic Types
Feingold syndrome is divided into type 1 and type 2 based on which gene is affected, and the distinction matters for both prognosis and genetic testing strategy.
Type 1 is caused by mutations or deletions in the MYCN gene on chromosome 2. MYCN encodes a protein that acts as a master regulator during embryonic development, controlling how quickly cells grow and divide in the brain, limbs, and gut. When one copy of MYCN is lost or broken, the developing embryo does not produce enough of this protein, and many organ systems are affected.4PubMed. Features of Feingold syndrome 1 dominate in subjects with 2p deletions including MYCN The mutations can range from tiny single-letter changes in the DNA to large chromosomal deletions that remove MYCN along with neighboring genes. The latter can sometimes produce additional features not typically seen in Feingold syndrome alone.
Type 2 is caused by deletions on chromosome 13 that remove the MIR17HG gene, which produces a cluster of small RNA molecules called the miR-17-92 microRNAs.5PubMed Central. First Patient Diagnosed as Feingold Syndrome Type 2 with Alport Syndrome and Review of the Current Literature These microRNAs normally fine-tune the activity of hundreds of other genes during development. When one copy of MIR17HG is deleted, the resulting shortage of microRNAs disrupts the same growth-and-differentiation programs that go wrong in type 1, which is why the two types look so similar clinically. Type 2, however, does not typically involve esophageal or duodenal atresia, and type 2 patients may be more likely to have cardiac anomalies.
Why Two Different Genes Produce Similar Symptoms
Because MYCN normally drives the production of the miR-17-92 microRNAs, researchers initially assumed both types of Feingold syndrome were caused by the same downstream breakdown. That turned out to be an oversimplification. Mouse studies have shown that losing the miR-17-92 cluster leads to overactive TGF-β signaling in developing limb cells, whereas losing MYCN instead suppresses a different growth pathway, PI3K signaling.6PubMed Central. Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models In those mouse experiments, blocking TGF-β signaling rescued the skeletal defects caused by microRNA loss but did nothing for the skeletal defects caused by MYCN loss. The practical takeaway is that despite their similar appearance, the two types of Feingold syndrome unfold through different molecular routes.
At the cellular level, the common thread is reduced cell proliferation. In developing limbs, loss of either gene means fewer cells are available to form the precartilage condensations that eventually become finger and toe bones. Research in mouse embryos showed that the proliferation defect occurs early, in the general limb bud tissue rather than in the cartilage-forming cells themselves. When the microRNA cluster was deleted only in cartilage-committed cells, no skeletal abnormalities appeared, confirming that the damage happens upstream.7Nature Communications. Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models
MYCN also plays a role in neural crest cells, which are a population of embryonic cells that migrate throughout the body and contribute to facial structures, parts of the heart, the gut’s nervous system, and more. Laboratory work on human neural crest stem cells has shown that suppressing MYCN slows their growth and pushes them toward premature differentiation, which helps explain why Feingold syndrome affects so many different organ systems at once.8PLOS ONE. MycN Is Critical for the Maintenance of Human Embryonic Stem Cell-Derived Neural Crest Stem Cells
Cognitive and Behavioral Features
Intellectual disability in Feingold syndrome is typically described as mild, but “mild” covers a broad spectrum. Some individuals attend mainstream schools with minimal support, while others need more structured help. Detailed scientific characterization of the learning profile in humans remains sparse, which is partly a consequence of the syndrome’s rarity.
A mouse model of Feingold syndrome type 2, created by deleting one copy of the miR-17-92 cluster, offered some of the first controlled data on neurobehavioral effects. These mice showed reduced body growth and fewer vocalizations during early development. As adults, they had measurable deficits in spatial learning, social recognition, and working memory compared to normal mice. The researchers also found altered levels of dopamine and serotonin in brain regions involved in planning and memory, suggesting a possible biological link between the microRNA shortage and cognitive difficulties.9PubMed Central. Neurobehavioral Alterations in a Genetic Murine Model of Feingold Syndrome 2 These findings in mice cannot be directly mapped onto human experience, but they point toward mechanisms that future clinical studies could investigate.
Reports on type 2 patients have also flagged memory and sleep problems as features that may be underrecognized.10PubMed Central. Growth hormone deficiency, aortic dilation, and neurocognitive issues in Feingold syndrome 2 Whether these are direct consequences of the genetic deletion or secondary effects of disrupted sleep, microcephaly, or other developmental factors is not yet clear.
Less Common Features
Beyond the core findings, a number of other organ systems can be involved, though each of these less common features appears in only a minority of patients. Vertebral anomalies, cardiac malformations, and hearing loss have all been documented.11PubMed. Feingold syndrome: clinical review and genetic mapping Kidney problems, including hydronephrosis and cystic dysplasia severe enough to require surgical removal of a kidney, have been reported in individual cases.11PubMed. Feingold syndrome: clinical review and genetic mapping
For type 2 specifically, three patients have been described with growth hormone deficiency linked to compression of the pituitary gland, aortic dilation, and joint contractures in the fingers, features not previously associated with the syndrome.10PubMed Central. Growth hormone deficiency, aortic dilation, and neurocognitive issues in Feingold syndrome 2 The fact that “new” features continue to appear in case reports reflects how few patients have been studied systematically. Clinicians caring for a child with Feingold syndrome generally keep an open mind about whether a seemingly unrelated problem might actually be part of the syndrome’s broader spectrum.
How Feingold Syndrome Is Diagnosed
Diagnosis starts with clinical suspicion, usually triggered by the combination of microcephaly with finger anomalies and, in many cases, gastrointestinal atresia. A hand X-ray showing shortened or absent middle phalanges of the second and fifth fingers is a strong clue. But because these features overlap with other syndromes, genetic testing is needed for confirmation.
For type 1, sequencing or deletion analysis of the MYCN gene on chromosome 2p24 is the standard approach. When a larger chromosomal deletion is suspected, chromosomal microarray analysis can identify the size and boundaries of the missing region.4PubMed. Features of Feingold syndrome 1 dominate in subjects with 2p deletions including MYCN For type 2, microarray or targeted deletion analysis looking at the MIR17HG region on chromosome 13q31 is used.5PubMed Central. First Patient Diagnosed as Feingold Syndrome Type 2 with Alport Syndrome and Review of the Current Literature
Because Feingold syndrome is autosomal dominant, confirming the diagnosis in a child also means the parents should be tested. In many families, one parent turns out to carry the same mutation with milder features that had gone unnoticed. That parent’s own siblings and future children are then at risk, so a single diagnosis in a newborn can reshape genetic counseling for the entire extended family.
Prenatal Detection
Feingold syndrome can sometimes be suspected before birth. Second-trimester ultrasound may reveal microcephaly and bilateral clinodactyly, both of which are measurable on routine scans. In one reported case, these ultrasound findings prompted molecular karyotyping that identified a roughly 342 kilobase deletion at 2p24.3 encompassing the MYCN gene, confirming the diagnosis prenatally.12PubMed Central. Prenatal Diagnosis of a Feingold Syndrome Pregnancy Complicated with Severe Preeclampsia: A Report of a Challenging Case In another case, fetal microcephaly detected on ultrasound and confirmed by fetal MRI led to array comparative genomic hybridization, which revealed a 1.5 megabase deletion in the Feingold syndrome region in both the fetus and the father.13PubMed Central. Feingold syndrome type 1: a rare cause of fetal microcephaly (prenatal diagnosis)
Prenatal diagnosis is most likely to happen when a parent is already known to carry the mutation. In families without a prior diagnosis, isolated fetal microcephaly has a long list of potential causes, and Feingold syndrome would not be at the top of that list for most clinicians. The finger abnormalities can be subtle on ultrasound and are easy to miss. Still, when microcephaly and clinodactyly are seen together in a fetus, Feingold syndrome deserves a place in the differential diagnosis.
Conditions That Look Similar
Several other genetic syndromes share individual features with Feingold syndrome, which can delay diagnosis. Esophageal atresia combined with other birth defects can also occur in VACTERL association, a pattern of anomalies involving the vertebrae, anus, heart, trachea, esophagus, kidneys, and limbs. VACTERL is not caused by a single gene and is typically a diagnosis of exclusion, so genetic testing to rule out Feingold syndrome is worthwhile whenever digital anomalies and microcephaly are part of the picture.
Cornelia de Lange syndrome can also feature microcephaly, limb anomalies, and intellectual disability, but it tends to involve more severe growth restriction, distinctive facial features (including a long philtrum and thin eyebrows that meet in the middle), and limb reductions that are more dramatic than the finger shortening in Feingold syndrome. Down syndrome, trisomy 18, and Fanconi anemia can all include hand anomalies and gastrointestinal problems, but each has additional features and a distinct genetic basis that testing can distinguish.
What makes Feingold syndrome stand out within this differential is the specific pattern of second and fifth finger clinodactyly with shortened middle phalanges plus toe syndactyly. That particular hand-and-foot combination, especially alongside microcephaly, is relatively distinctive and should prompt MYCN testing even when other features are ambiguous.
Living with Feingold Syndrome
Management is driven by which features are present and how severe they are. Newborns with esophageal or duodenal atresia need surgery early, and these operations are generally well-established procedures with good outcomes when performed at experienced pediatric surgical centers. After the immediate neonatal period, ongoing care often involves multiple specialists: a geneticist to coordinate the overall picture, an orthopedist or hand surgeon if finger contractures or function are concerns, a developmental pediatrician for cognitive monitoring, and sometimes a cardiologist or nephrologist depending on what screening reveals.
Microcephaly in Feingold syndrome does not always mean the brain is structurally abnormal, but head growth should be tracked over time. In rare cases, craniosynostosis (premature fusion of skull bones) has been reported alongside the microcephaly, and at least one patient required cranial vault reconstruction surgery to relieve pressure on the brain.14Current Pediatric Research. Importance of Multi-Disciplinary Team Approach in Feingold Syndrome That case illustrates how managing even a “mild” syndrome can become complex when features interact unpredictably.
Growth hormone deficiency has been identified in some type 2 patients, and when present, it may be treatable with growth hormone replacement therapy. Aortic dilation, also reported in type 2, calls for periodic cardiac imaging to monitor for progression.10PubMed Central. Growth hormone deficiency, aortic dilation, and neurocognitive issues in Feingold syndrome 2 Because the full spectrum of the syndrome is still being defined, clinicians generally recommend baseline screening of the heart, kidneys, and hearing at the time of diagnosis, even if no problems are clinically apparent.
What Research Is Still Sorting Out
Mouse models have been invaluable for understanding how Feingold syndrome develops, but they also highlight gaps. Mice missing one copy of MYCN in the germline do not develop detectable skeletal abnormalities the way humans do, even though deleting MYCN specifically in developing limbs produces severe brachydactyly and syndactyly that closely mirrors human type 1.7Nature Communications. Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models This discrepancy suggests that compensatory mechanisms in mice can partially make up for losing one MYCN copy in ways that human biology cannot. Understanding that compensation could eventually reveal targets for intervention.
The discovery that TGF-β inhibition can rescue the skeletal defects in the type 2 mouse model is especially intriguing. No one is proposing TGF-β inhibitors as a prenatal treatment today, but identifying the specific signaling pathway responsible for a birth defect is the kind of mechanistic finding that occasionally leads to therapeutic ideas years down the line. For now, the more immediate value of these molecular insights is in sharpening the diagnostic distinction between type 1 and type 2 and in guiding genetic counselors who need to explain to families why two different genes can produce such similar outcomes.
One persistent challenge is the syndrome’s variability. Two siblings carrying the identical MYCN mutation can present very differently, with one needing neonatal surgery for esophageal atresia and the other showing only mild finger shortening and a slightly small head. The factors that modify severity, whether other genes, random developmental noise, or environmental influences, remain poorly understood. Large registries and natural history studies, difficult to assemble for a rare condition, would help clarify the range of outcomes families can expect.